In comparison to the saline-treated animal group, SFN-pre-treated animals showed reduced gene expression of CSC markers, including Nanog, forkhead box D3 (FOXD3), Wnt3, ALDH1A1, and Notch4 during primary tumor growth. The gene discussed is FOXD3; the disease is neoplasm.